Cannabryl

“We use Cannabis (for medical use) in order to obtain cannabinoids, which are macro-molecules stored by the trichomes of the plant. In order to assess the quality of our products, we use an accurate third-party testing system that can provide us a clear insight of cannabinoid potency, levels of active components, and variety”.

Cannabryl use analytical methods in order to produce a stable, reliable, and consistent product.

Selective breeding is a valuable tool in order to characterize specific production and understand mechanisms inside the plant that determine the levels of active constituents (flavonoids, terpenoids, cannabinoids…) for better medical application.

Each Cannabis strain produces a variety of compounds at different concentrations throughout flowering time; hence, their production can be scheduled around analysis, in order to obtain more, or less, of certain important constituents, based on therapeutic needs.

We are heavily engaged in studying and researching the Intricacies of Human endocannabinoid system and its receptors. We have a research-based relationship with the Hebrew University of Israel and Eminent Medical schools in India. Our Moto is to serve and present new alternatives to patients suffering from epilepsy, cancer, dementia, Alzheimer’s, pain, stress, side effects of chemo and radiation therapies, and several other chronic diseases.

So far IBS has gained Expertise in Cannabis Extraction without losing any medically beneficial components including terpenes and cannabinoids. Our research associates, Pharmacists, and Doctors are putting continuous efforts in new drug development, clinical trials, and clinical validations to offer the medical ecosystem an alternative new treatment. As part of our Product quality control, every batch undergoes in-house Lab testing, Government of India Laboratory Testing, and third-party testing from a European laboratory, while these tests have proved that our medicinal compound extracts are of high grade and comparable to international standards.